Cell (1)
Launched (1)
Human (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
CHEK-ATF131 | HEK293 | Human 5-HT1A (Luc) HEK293 Reporter Cell |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Crenigacestat | JSMD-194; LY-3039478; BMS-986405 | Phase 2 Clinical | Eli Lilly And Company | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Neoplasm Metastasis; Leukemia, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Hepatocellular; Lymphoma; Lymphoma, T-Cell; Leukemia, B-Cell; Breast Neoplasms; Leiomyosarcoma; Sarcoma; Cholangiocarcinoma; Multiple Myeloma; Carcinoma, Adenoid Cystic; Colonic Neoplasms; Triple Negative Breast Neoplasms; Solid tumours; Lymphoma, B-Cell | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



